Ultra- sustained-release multi-particulate dosage form of Doxycycline as a platform of repurposing therapeutics in the fight against COVID 19: in-vitro and in-silico study - Egyptian Knowledge Bank - troweb

216254

Ultra- sustained-release multi-particulate dosage form of Doxycycline as a platform of repurposing therapeutics in the fight against COVID 19: in-vitro and in-silico study

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Doxycycline and Minocycline Drugs as a Treatment Proposal for Inhibition of ARDS and Inflammatory Cytokines of SARS-CoV-2

Article

Pharmacological studies on tetracycline and tetracycline nanoemulsion formulas

Article

Silica Nanoparticles as a Potential Carrier for Doxycycline Hyclate

Article

Pharmacokinetic properties of single doxycycline dose orally administered in the African catfish (Clarias gariepinus)

Article

Synthesis and In silico Docking Study of Some New Quinazolin-2,4-diones Targeting COVID-19 (SARS-Cov-2) Main Protease: A Search for Anti-Covid19 Drug Candidates

Article

Novel In Situ Gel for Molnupiravir-Loaded Niosomes: Design, In Vitro Characterization and In Vivo Evaluation ‎

Article

ADVANCES AND DEVELOPMENTS IN DRUG REPURPOSING; STATE OF ART

Article

PREPARATION AND EVALUATION OF SUSTAINED RELEASE MATRIX FORMULATIONS OF VORICONAZOLE

Article

New antimicrobial tetracycline analogue A (Nitrocycline) designed using chemoinformatics

Article

Recent Analytical Methodologies for Determination of Anti-Viral COVID-19 Drugs: A Review